携泰健康 (833669.oc)

+ 收藏

现金流量表(携泰健康)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 167,537,492.48579,041,336.70270,149,908.41512,302,374.65208,640,912.51
 收到其他与经营活动有关的现金(元) 6,156,905.889,242,545.816,504,647.0122,208,432.7520,879,149.93
 经营活动现金流入小计(元) 173,694,398.36588,283,882.51276,654,555.42534,510,807.40229,520,062.44
 购买商品、接受劳务支付的现金(元) 133,185,407.98466,761,044.35215,509,368.05353,854,079.74135,661,290.25
 支付给职工以及为职工支付的现金(元) 20,756,652.4840,841,967.3721,377,174.1239,616,094.0420,037,104.73
 支付的各项税费(元) 12,069,657.6130,797,968.7114,376,138.3125,385,847.2112,521,276.25
 支付其他与经营活动有关的现金(元) 18,593,827.9851,505,883.8717,598,979.1334,465,771.6219,236,663.12
 经营活动现金流出小计(元) 184,605,546.05589,906,864.30268,861,659.61453,321,792.61187,456,334.35
 经营活动产生的现金流量净额(元) -10,911,147.69-1,622,981.797,792,895.8181,189,014.7942,063,728.09
二、投资活动产生的现金流量
 收回投资收到的现金(元) 135,828,479.01465,733,712.00198,733,712.00199,350,000.00112,350,000.00
 取得投资收益收到的现金(元) 906,992.493,950,717.212,719,199.291,216,473.56424,109.82
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) -1,970.00---
 处置子公司及其他营业单位收到的现金净额(元) -4,060,000.00---
 收到其他与投资活动有关的现金(元) 104,314.93-157,005.30-31,770.89
 投资活动现金流入小计(元) 136,839,786.43473,746,399.21201,609,916.59200,566,473.56112,805,880.71
 购建固定资产、无形资产和其他长期资产支付的现金(元) 15,680,392.7311,282,973.611,252,015.003,284,993.708,048,160.00
 投资支付的现金(元) 75,300,000.00447,933,712.00138,733,712.00241,514,794.00132,514,794.00
 投资活动现金流出小计(元) 90,980,392.73459,216,685.61139,985,727.00244,799,787.70140,562,954.00
 投资活动产生的现金流量净额(元) 45,859,393.7014,529,713.6061,624,189.59-44,233,314.14-27,757,073.29
三、筹资活动产生的现金流量
 收到其他与筹资活动有关的现金(元) ---72,112.07-
 筹资活动现金流入小计(元) ---72,112.07-
 分配股利、利润或偿付利息支付的现金(元) 42,000,000.0034,000,000.0034,000,000.0036,000,000.0036,000,000.00
 支付其他与筹资活动有关的现金(元) -56,989.70-93,976.80-
 筹资活动现金流出小计(元) 42,000,000.0034,056,989.7034,000,000.0036,093,976.8036,000,000.00
 筹资活动产生的现金流量净额(元) -42,000,000.00-34,056,989.70-34,000,000.00-36,021,864.73-36,000,000.00
五、现金及现金等价物净增加额(元) -7,051,753.99-21,150,257.8935,417,085.40933,835.92-21,693,345.20
 加:期初现金及现金等价物余额(元) 16,221,776.6037,372,034.4937,372,034.4936,438,198.5736,438,198.57
 期末现金及现金等价物余额(元) 9,170,022.6116,221,776.6072,789,119.8937,372,034.4914,744,853.37
补充资料:
 净利润(元) 18,364,849.5549,480,541.2626,411,314.3538,617,746.0424,432,462.40
 资产减值准备(元) -87,302.36-1,455,752.611,455,752.61-377,976.98
 固定资产和投资性房地产折旧(元) 690,558.201,367,145.86683,361.921,411,671.20712,031.03
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 690,558.201,367,145.86683,361.921,411,671.20712,031.03
 无形资产摊销(元) 238,771.89590,224.60114,573.81219,305.1618,806.58
 长期待摊费用摊销(元) 164,708.76329,417.52164,708.76402,089.12237,380.36
 固定资产报废损失(元) -22,278.88-480.59-
 公允价值变动损失(元) --21,836.01--1,479,851.56-
 财务费用(元) -375,071.0294.07-172,560.017,028.12-60,526.72
 投资损失(元) -907,187.22-6,336,378.20-1,365,002.22-1,133,034.39-1,531,274.52
 递延所得税(元) -258,789.92501,140.30-167,948.29-860,705.13258,907.50
  其中:递延所得税资产减少(元) -258,789.92501,140.30-167,948.29-773,195.46116,933.29
 递延所得税负债增加(元) ----87,509.67141,974.21
 存货的减少(元) 14,085,959.34-17,707,746.48-5,025,297.13-5,414,831.60-13,321,378.39
 经营性应收项目的减少(元) 82,387,172.06-21,971,582.80100,748,236.1233,647,290.37118,397,669.95
 经营性应付项目的增加(元) -126,481,073.22-8,086,659.39-112,433,070.5514,600,196.51-86,795,328.55
 现金的期末余额(元) 9,170,022.6116,221,776.6072,789,119.8937,372,034.4914,744,853.37
 减:现金的期初余额(元) 16,221,776.6037,372,034.4937,372,034.4936,438,198.5736,438,198.57
 现金及现金等价物的净增加额(元) -7,051,753.99-21,150,257.8935,417,085.40933,835.92-21,693,345.20
公告日期 2024-08-222024-04-192023-08-252023-04-192022-08-25
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院